Shopping Cart
Remove All
Your shopping cart is currently empty
sEH/HDAC6-IN-2 is an effective dual inhibitor of soluble epoxide hydrolase (sEH) and HDAC6, demonstrating IC50 values of 0.9 nM for human sEH, 46.8 nM for mouse sEH, and 8 nM for HDAC6. It is used in research focused on inflammatory pain.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,670 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,180 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $2,800 | 8-10 weeks | 8-10 weeks |
| Description | sEH/HDAC6-IN-2 is an effective dual inhibitor of soluble epoxide hydrolase (sEH) and HDAC6, demonstrating IC50 values of 0.9 nM for human sEH, 46.8 nM for mouse sEH, and 8 nM for HDAC6. It is used in research focused on inflammatory pain. |
| Targets&IC50 | HDAC6:0.008 μM, Human sEh:0.0009 μM, HDAC8:0.062 μM, HDAC1:1.151 μM, Mouse sEh:0.0468 μM, HDAC3:1.276 μM, HDAC11:0.464 μM, HDAC2:0.492 μM |
| In vitro | sEH/HDAC6-IN-2 exhibits selective inhibition towards HDAC6, demonstrated by its significant selectivity indices (HDAC1/HDAC6 = 144, HDAC2/HDAC6 = 62, HDAC3/HDAC6 = 160, HDAC8/HDAC6 = 8, HDAC11/HDAC6 = 58). When administered at concentrations of 1-2 μM for 24 hours, sEH/HDAC6-IN-2 (compound 28g) induces an increase in acetylation of α-tubulin without affecting histone H3, indicating a selective inhibition of HDAC6. |
| In vivo | sEH/HDAC6-IN-2 (compound 28g; 30 mg/kg; intraperitoneal injection; single dose) alleviated inflammation-induced pain in mice following formalin exposure. |
| Molecular Weight | 580.02 |
| Formula | C27H32ClF2N5O5 |
| Cas No. | 3009011-58-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.